Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1757-4749
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones ; volume:9 ; number:1 ; day:25 ; month:8 ; year:2017 ; pages:1-8 ; date:12.2017
Gut pathogens ; 9, Heft 1 (25.8.2017), 1-8, 12.2017

Urheber
Binyamin, Dana
Beteiligte Personen und Organisationen
Pastukh, Nina
On, Avi
Paritsky, Maya
Peretz, Avi
SpringerLink (Online service)

DOI
10.1186/s13099-017-0198-5
URN
urn:nbn:de:1111-2017110517453
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:35 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Binyamin, Dana
  • Pastukh, Nina
  • On, Avi
  • Paritsky, Maya
  • Peretz, Avi
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Therapie der Helicobacter pylori-Infektion bei Patienten mit gegen Metronidazol und Clarithromycin doppelresistenten Helicobacter pylori-Stämmen

Hochschulschrift

Therapie der Helicobacter pylori-Infektion bei Patienten mit gegen Metronidazol und Clarithromycin doppelresistenten Helicobacter pylori-Stämmen

Genotypic determination of resistance and heteroresistance to clarithromycin in Helicobacter pylori isolates from antrum and corpus of Colombian symptomatic patients

Genotypic determination of resistance and heteroresistance to clarithromycin in Helicobacter pylori isolates from antrum and corpus of Colombian symptomatic patients

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori

Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori

Detection of Clarithromycin Resistance in Helicobacter pylori Using MmaxSure™ H. pylori & ClaR Assay

Detection of Clarithromycin Resistance in Helicobacter pylori Using MmaxSure™ H. pylori & ClaR Assay

Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections

Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections

Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains in Zambia: A Sub-Saharan African Country

Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains in Zambia: A Sub-Saharan African Country

Helicobacter pylori

Helicobacter pylori

Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients

Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients

Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru

Highly clarithromycin-resistant Helicobacter pylori infection in asymptomatic children from a rural community of Cajamarca-Peru

Low rate of recurrence of Helicobacter Pylori infection in spite of high clarithromycin resistance in Pakistan

Low rate of recurrence of Helicobacter Pylori infection in spite of high clarithromycin resistance in Pakistan

PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori

PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?

Verbundene Objekte